1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Molybdenum Cofactor Deficiency, Complementation Group A: new trials by email Literature Review of Molybdenum Cofactor Deficiency, Complementation Group A trials Research Report on Molybdenum Cofactor Deficiency, Complementation Group A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of ORGN001 (Formerly ALXN1101) in Neonates, Infants and Children With Molybdenum Cofactor Deficiency (MOCD) Type A ORGN001 (formerly ALXN1101) - Molybdenum Cofactor Deficiency, Type A | Phase 2 / Phase 3 | Completed | Origin Biosciences | 5 | 2016-05-01 | 2023-10-17 |
Molybdenum cofactor deficiency (1)
Israel (1) · Norway (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)